Endovia Health Sciences, Inc. (EDVA): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.2K
Year ended 2024-12-31
-23.8%
5-year compound annual growth
$102.7K2014-12-31: $30.4K2015-12-31: $26.9K2016-12-31: $58.4K2017-12-31: $58.3K2018-12-31: $75.6K2019-12-31: $12.6K2020-12-31: $91.1K2021-12-31: $02022-12-31: $102.7K2023-12-31: $14.1K2024-12-31: $3.2K$3.2K
2014-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$3.2K-77.1%2025-07-11, From 2024-01-01
2023-12-31$14.1K-86.3%2025-07-11, From 2023-01-01
2022-12-31$102.7Kn/a2024-03-29, From 2022-01-01
2021-12-31$0-100.0%2023-03-31, From 2021-01-01
2020-12-31$91.1K+625.5%2022-03-31, From 2020-01-01
2019-12-31$12.6K-83.4%2021-03-08, From 2019-01-01
2018-12-31$75.6K+29.8%2020-03-27, From 2018-01-01
2017-12-31$58.3K-0.3%2019-03-29, From 2017-01-01
2016-12-31$58.4K+117.4%2018-04-02, From 2016-01-01
2015-12-31$26.9Kn/c2017-03-28, From 2015-01-01
2014-12-31$30.4Kn/a2016-10-03, From 2014-01-01